文献速递临床试验与 GCP真实世界研究与卫生经济

养老院中药师独立处方者有效性与安全性评估:整群随机对照试验

Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trial.
PubMed 文献 · BMJ · 2023-02-14

该整群随机对照试验将49个由药师独立处方者、全科诊所和养老院组成的三角单元及882名≥65岁居民随机分组,干预组接受每周一次、持续六个月的药师主导药学照护。六个月内干预组跌倒发生率为每人1.55次,对照组为每人1.26次,校正后跌倒风险比为0.91(95%CI 0.66至1.26),未达统计学显著;药物负担指数显著利于干预组,未发现不良事件或安全问题。

要点

  • 六个月内干预组跌倒发生率为每人1.55次,对照组为每人1.26次,校正后风险比0.91(95%CI 0.66至1.26),未达统计学显著。
  • 药物负担指数显著利于干预组,其余次要结局组间无显著差异。
  • 药师独立处方者干预中有三分之一(185/566;32.7%)涉及与跌倒相关的药物,未发现不良事件或安全问题。

核心结论

  • 主要结局跌倒变化未达统计学显著,随访限制为六个月及预计影响跌倒的干预比例较小可能解释这一结果。
  • 药物负担指数显著降低,预计将为患者带来未来临床获益。
  • 该大型试验发现每周强化药师干预对养老院居民安全且接受度良好。

研究设计与样本

  • 整群随机对照试验,以药师独立处方者、全科诊所和一到三家关联养老院组成的三角单元为整群。
  • 共随机49个三角单元和882名居民,参与者为≥65岁、至少服用一种处方药的养老院居民,每个三角单元招募20名居民。
  • 干预组每位药师独立处方者通过每周访视、持续六个月为约20名居民提供药学照护,包括制定药学照护计划、药物审查/核对、培训员工、支持药物相关操作、 deprescribing(减处方)和处方授权;对照组接受常规照护。
  • 主要结局为六个月时每人跌倒率,按意向性治疗分析并校正预后变量;假设跌倒减少21%,需880名居民,允许20%失访。

主要发现

  • 参与者入组时平均年龄85岁,70%为女性。
  • 六个月时干预组记录697次跌倒(每人1.55次),对照组记录538次跌倒(每人1.26次)。
  • 校正所有模型协变量后,干预组相比对照组的跌倒率风险比为0.91(95%CI 0.66至1.26),未达统计学显著。
  • 除药物负担指数显著利于干预组外,其余次要结局组间无显著差异。
  • 药师独立处方者干预中有三分之一(185/566;32.7%)涉及与跌倒相关的药物,未发现不良事件或安全问题。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 随访限制为六个月,且预计影响跌倒的干预比例较小,可能解释主要结局未达显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the effectiveness, cost effectiveness (to be reported elsewhere), and safety of pharmacy independent prescribers in care homes. DESIGN: Cluster randomised controlled trial, with clusters based on triads of a pharmacist independent prescriber, a general practice, and one to three associated care homes. SETTING: Care homes across England, Scotland, and Northern Ireland, their associated general practices, and pharmacy independent prescribers, formed into triads. PARTICIPANTS: 49 triads and 882 residents were randomised. Participants were care home residents, aged ≥65 years, taking at least one prescribed drug, recruited to 20 residents/triad. INTERVENTION: Each pharmacy independent prescriber provided pharmaceutical care to approximately 20 residents across one to three care homes, with weekly visits over six months. Pharmacy independent prescribers developed a pharmaceutical care plan for each resident, did medicines reviews/reconciliation, trained staff, and supported with medicines related procedures, deprescribing, and authorisation of prescriptions. Participants in the control group received usual care. MAIN OUTCOMES MEASURES: The primary outcome was fall rate/person at six months analysed by intention to treat, adjusted for prognostic variables. Secondary outcomes included quality of life (EQ-5D by proxy), Barthel score, Drug Burden Index, hospital admissions, and mortality. Assuming a 21% reduction in falls, 880 residents were needed, allowing for 20% attrition. RESULTS: The average age of participants at study entry was 85 years; 70% were female. 697 falls (1.55 per resident) were recorded in the intervention group and 538 falls (1.26 per resident) in the control group at six months. The fall rate risk ratio for the intervention group compared with the control group was not significant (0.91, 95% confidence interval 0.66 to 1.26) after adjustment for all model covariates. Secondary outcomes were not significantly different between groups, with exception of the Drug Burden Index, which significantly favoured the intervention. A third (185/566; 32.7%) of pharmacy independent prescriber interventions involved medicines associated with falls. No adverse events or safety concerns were identified. CONCLUSIONS: Change in the primary outcome of falls was not significant. Limiting follow-up to six months combined with a small proportion of interventions predicted to affect falls may explain this. A significant reduction in the Drug Burden Index was realised and would be predicted to yield future clinical benefits for patients. This large trial of an intensive weekly pharmacist intervention with care home residents was also found to be safe and well received. TRIAL REGISTRATION: ISRCTN 17847169.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Holland R, Bond C, Alldred DP, et al. Evaluation of effectiveness and safety of pharmacist independent prescribers in care homes: cluster randomised controlled trial. BMJ. 2023. PMID: 36787910. doi:10.1136/bmj-2022-071883

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。